Canagliflozin and Renal Outcomes in Diabetic Nephropathy

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

1 Citation (Scopus)
244 Downloads (Pure)
Original languageEnglish
Pages (from-to)1089
Number of pages1
JournalNew England Journal of Medicine
Volume381
Issue number11
DOIs
Publication statusPublished - 12-Sep-2019

Keywords

  • Canagliflozin
  • Diabetes Mellitus, Type 2
  • Diabetic Nephropathies
  • Humans
  • Kidney
  • Sodium-Glucose Transporter 2 Inhibitors

Cite this